PMC:7417114 / 27375-27501 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T140","span":{"begin":69,"end":77},"obj":"Body_part"}],"attributes":[{"id":"A140","pred":"fma_id","subj":"T140","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"AZ5104, active metabolite of osimertinib, downregulates Th17-related cytokine production via inhibition of SRC-ERK-STAT3\n(127)"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T327","span":{"begin":8,"end":14},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T328","span":{"begin":107,"end":110},"obj":"http://purl.obolibrary.org/obo/CLO_0009132"}],"text":"AZ5104, active metabolite of osimertinib, downregulates Th17-related cytokine production via inhibition of SRC-ERK-STAT3\n(127)"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T235","span":{"begin":15,"end":25},"obj":"Chemical"},{"id":"T236","span":{"begin":29,"end":40},"obj":"Chemical"}],"attributes":[{"id":"A235","pred":"chebi_id","subj":"T235","obj":"http://purl.obolibrary.org/obo/CHEBI_25212"},{"id":"A236","pred":"chebi_id","subj":"T236","obj":"http://purl.obolibrary.org/obo/CHEBI_90943"}],"text":"AZ5104, active metabolite of osimertinib, downregulates Th17-related cytokine production via inhibition of SRC-ERK-STAT3\n(127)"}

{"project":"LitCovid-PubTator","denotations":[{"id":"902","span":{"begin":111,"end":114},"obj":"Gene"}],"attributes":[{"id":"A902","pred":"tao:has_database_id","subj":"902","obj":"Gene:5594"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"AZ5104, active metabolite of osimertinib, downregulates Th17-related cytokine production via inhibition of SRC-ERK-STAT3\n(127)"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T83","span":{"begin":69,"end":88},"obj":"http://purl.obolibrary.org/obo/GO_0001816"}],"text":"AZ5104, active metabolite of osimertinib, downregulates Th17-related cytokine production via inhibition of SRC-ERK-STAT3\n(127)"}

{"project":"LitCovid-sentences","denotations":[{"id":"T191","span":{"begin":121,"end":126},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"AZ5104, active metabolite of osimertinib, downregulates Th17-related cytokine production via inhibition of SRC-ERK-STAT3\n(127)"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T636","span":{"begin":15,"end":25},"obj":"CHEBI:25212;CHEBI:25212"},{"id":"T637","span":{"begin":29,"end":40},"obj":"CHEBI:25675;CHEBI:25675"},{"id":"T638","span":{"begin":107,"end":110},"obj":"PR:000027234"},{"id":"T639","span":{"begin":115,"end":120},"obj":"PR:000002089"}],"text":"AZ5104, active metabolite of osimertinib, downregulates Th17-related cytokine production via inhibition of SRC-ERK-STAT3\n(127)"}